Categorical complexities of Plasmodium falciparum malaria in individuals is associated with genetic variations in ADORA2A and GRK5 genes

Infection, Genetics and Evolution

Volumn 34, Issue , 2015, Pages 188-199

  Gupta, Himanshu ^a   Jain, Aditya ^a   Saadi, Abdul Vahab ^a   Vasudevan, Thanvanthri G ^a   Hande, Manjunath H ^b   D'Souza, Sydney C ^c   Ghosh, Susanta K ^d   Umakanth, Shashikiran ^e   Satyamoorthy, Kapaettu ^a  

^a MANIPAL SCHOOL OF LIFE SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c KASTURBA MEDICAL COLLEGE   (India)

^d National Institute of Malaria Research   (India)

^e MELAKA MANIPAL MEDICAL COLLEGE   (India)

Author keywords

ADORA2A; Association; Gene interaction; GRK5; Malaria; SNPs

Indexed keywords

ADENOSINE A2A RECEPTOR; CREATININE; G PROTEIN COUPLED RECEPTOR KINASE 5;

ADORA2A GENE; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA SEQUENCE; FEMALE; GENE ACTIVITY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRK5 GENE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROBIAL GENE; MOLECULAR DOCKING; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CHEMISTRY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PARASITOLOGY; PHYSIOLOGY; PROTECTION; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MOLECULAR DOCKING SIMULATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; RECEPTOR, ADENOSINE A2A; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84937837668     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.06.010     Document Type: Article

References (62)

1. Alsene K., Deckert J., Sand P., de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003, 28:1694-1702.
2. Auburn S., Fry A.E., Clark T.G., Campino S., Diakite M., Green A., Richardson A., Jallow M., Sisay-Joof F., Pinder M., Molyneux M.E., Taylor T.E., Haldar K., Rockett K.A., Kwiatkowski D.P. Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis. PLoS One 2010, 5:e10017.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Berman P.A., Human L. Hypoxanthine depletion induced by xanthine oxidase inhibits malaria parasite growth in vitro. Adv. Exp. Med. Biol. 1991, 309:165-168.
5. Berman P.A., Human L., Freese J.A. Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro. J. Clin. Invest. 1991, 88:1848-1855.
6. Chen Q., Schlichtherle M., Wahlgren M. Molecular aspects of severe malaria. Clin. Microbiol. Rev. 2000, 13:439-450.
7. Coban C., Ishii K.J., Kawai T., Hemmi H., Sato S., Uematsu S., Yamamoto M., Takeuchi O., Itagaki S., Kumar N., Horii T., Akira S. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005, 201:19-25.
8. Day N.P., Hien T.T., Schollaardt T., Loc P.P., Chuong L.V., Chau T.T., Mai N.T., Phu N.H., Sinh D.X., White N.J., Ho M. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 1999, 180:1288-1297.
9. de Koning H.P., Bridges D.J., Burchmore R.J. Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. FEMS Microbiol. Rev. 2005, 29:987-1020.
10. Deckert J., Nothen M.M., Albus M., Franzek E., Rietschel M., Ren H., Stiles G.L., Knapp M., Weigelt B., Maier W., Beckmann H., Propping P. Adenosine A1 receptor and bipolar affective disorder: systematic screening of the gene and association studies. Am. J. Med. Genet. 1998, 81:18-23.
11. Deckert J., Nothen M.M., Franke P., Delmo C., Fritze J., Knapp M., Maier W., Beckmann H., Propping P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry 1998, 3:81-85.
12. Dhaenens C.M., Burnouf S., Simonin C., Van Brussel E., Duhamel A., Defebvre L., Duru C., Vuillaume I., Cazeneuve C., Charles P., Maison P., Debruxelles S., Verny C., Gervais H., Azulay J.P., Tranchant C., Bachoud-Levi A.C., Dürr A., Buée L., Krystkowiak P., Sablonnière B., Blum D. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol. Dis. 2009, 35:474-476. Huntington French Speaking Network.
13. Ding S., Jiang T., He J., Qin B., Lin S. Tagging single nucleotide polymorphisms in the IRF1 and IRF8 genes and tuberculosis susceptibility. PLoS One 2012, 7:e42104.
14. Dodoo D., Omer F.M., Todd J., Akanmori B.D., Koram K.A., Riley E.M. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 2002, 185:971-979.
15. Dorn G.W., Liggett S.B. Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure. Mol. Pharmacol. 2009, 76:466-480.
16. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-16.
17. Facheris M.F., Schneider N.K., Lesnick T.G., de Andrade M., Cunningham J.M., Rocca W.A., Maraganore D.M. Coffee caffeine-related genes and Parkinson's disease: a case-control study. Mov. Disord. 2008, 23:2033-2040.
18. Fernandes R.C., Hasan M., Gupta H., Geetha K., Rai P.S., Hande M.H., D'Souza S.C., Adhikari P., Brand A., Satyamoorthy K. Host genetic variations in glutathione-S-transferases, superoxide dismutases and catalase genes influence susceptibility to malaria infection in an Indian population. Mol. Genet. Genomics 2015, 10.1007/s00438-014-0984-4.
19. Fredholm B.B., Chern Y., Franco R., Sitkovsky M. Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 2007, 83:263-276.
20. Freitag C.M., Agelopoulos K., Huy E., Rothermundt M., Krakowitzky P., Meyer J., Deckert J., von Gontard A., HohoffC. Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur. Child Adolesc. Psychiatry 2010, 19:67-74.
21. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am. J. Epidemiol. 2002, 155:478-484.
22. Gauderman, W.J., Morrison, J.M., 2006. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. Available at:. http://%20hydra.usc.edu/gxe.
23. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.
24. Gupta H., Sakharwade S.C., Angural A., Kotambail A., Bhat G.K., Hande M.H., D'Souza S.C., Rao P., Kumari V., Saadi A.V., Satyamoorthy K. Evidence for genetic linkage between a polymorphism in the GNAS gene and malaria in South Indian population. Acta Trop. 2013, 128:571-577.
25. Harrison T., Samuel B.U., Akompong T., Hamm H., Narla M., Lomasney J.W., Haldar K. Erythrocyte G protein-coupled receptor signalling in malarial infection. Science 2003, 301:1734-1736.
26. Hasko G., Linden J., Cronstein B., Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 2008, 7:759-770.
27. Hill A.V. The immunogenetics of resistance to malaria. Proc. Assoc. Am. Physicians 1999, 111:272-277.
28. HohoffC., Mullings E.L., Heatherley S.V., Freitag C.M., Neumann L.C., Domschke K., Krakowitzky P., Rothermundt M., Keck M.E., Erhardt A., Unschuld P.G., Jacob C., Fritze J., Bandelow B., Maier W., Holsboer F., Rogers P.J., Deckert J. Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J. Psychiatr. Res. 2010, 44:930-937.
29. Jason J., Archibald L.K., Nwanyanwu O.C., Bell M., Buchanan I., Larned J., Kazembe P.N., Dobbie H., Parekh B., Byrd M.G., Eick A., Han A., Jarvis W.R. Cytokines and malaria parasitemia. Clin. Immunol. 2001, 100:208-218.
30. Kim S.H., Kim Y.K., Park H.W., Kim S.H., Kim S.H., Ye Y.M., Min K.U., Park H.S. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir. Med. 2009, 103:356-363.
31. Kimchi-Sarfaty C., Mi Oh J., Kim I., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 26:525-528.
32. Krishnegowda G., Hajjar A.M., Zhu J., Douglass E.J., Uematsu S., Akira S., Woods A.S., Gowda D.C. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors glycosylphosphatidylinositol (GPI) structural requirement and regulation of GPI activity. J. Biol. Chem. 2005, 280:8606-8616.
33. Lauer S., VanWye J., Harrison T., McManus H., Samuel B.U., Hiller N.L., Mohandas N., Haldar K. Vacuolar uptake of host components and a role for cholesterol and sphingomyelin in malarial infection. EMBO J. 2000, 19:3556-3564.
34. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., He L., Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res. 2009, 19:519-523.
35. Liggett S.B., Cresci S., Kelly R.J., Syed F.M., Matkovich S.J., Hahn H.S., Diwan A., Martini J.S., Sparks L., Parekh R.R., Spertus J.A., Koch W.J., Kardia S.L., Dorn G.W. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat. Med. 2008, 14:507-510.
36. Lindahl E., Azuara C., Koehl P., Delarue M. NOMAD-Ref: visualization deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic Acids Res. 2006, 34:52-56.
37. Lou X.Y., Chen G.B., Yan L., Ma J.Z., Zhu J., Elston R.C., Li M.D. A generalized combinatorial approach for detecting gene by gene and gene by environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 2007, 80:1125-1137.
38. Malhotra A.K. Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain. Neurotox. Res. 2004, 6:51-56.
39. May L., van Bodegom D., Frölich M., van Lieshout L., Slagboom P.E., Westendorp R.G., Kuningas M. Polymorphisms in TLR4 and TLR2 genes cytokine production and survival in rural Ghana. Eur. J. Hum. Genet. 2010, 18:490-495.
40. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
41. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis of malaria. Nature 2002, 415:673-679.
42. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., Otchwemah R.N., Dietz E., Ehrhardt S., Schröder N.W., Bienzle U., Schumann R.R. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. 2006, 103:177-182.
43. Murphy S.C., Samuel B.U., Harrison T., Speicher K.D., Speicher D.W., Reid M.E., Prohaska R., Low P.S., Tanner M.J., Mohandas N., Haldar K. Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Blood 2004, 103:1920-1928.
44. Murphy S.C., Hiller N.L., Harrison T., Lomasney J.W., Mohandas N., Haldar K. Lipid rafts and malaria parasite infection of erythrocytes. Mol. Membr. Biol. 2006, 23:81-88.
45. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
46. Pichyangkul S., Yongvanitchit K., Kum-arb U., Hemmi H., Akira S., Krieg A.M., Heppner D.G., Stewart V.A., Hasegawa H., Looareesuwan S., Shanks G.D., Miller R.S. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 2004, 172:4926-4933.
47. Quashie N.B., Ranford-Cartwright L.C., de Koning H.P. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter. Malar. J. 2010, 9:36. 10.1186/1475-2875-9-36.
48. Saadi A.V., Gupta H., Angural A., Dhanya S.K., Mony S., Oberoi D., D'Souza S C., Sahoo R.C., Hande M.H., Gopinath P.M., Satyamoorthy K. Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population. Infect. Genet. Evol. 2013, 20:140-147.
49. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
50. Samuel B.U., Mohandas N., Harrison T., McManus H., Rosse W., Reid M., Haldar K. The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. JBC 2001, 276:29319-29329.
51. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. 1977, 74:5463-5467.
52. Sauna Z.E., Kimchi-Sarfaty C., Ambudkar S.V., Gottesman M.M. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res. 2007, 67:9609-12.
53. Sharma S., Das M., Kumar A., Marwaha V., Shankar S., Singh P., Raghu P., Aneja R., Grover R., Arya V., Dhir V., Gupta R., Kumar U., Juyal R.C.K.T.B. Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenet. Genomics 2009, 19:823-828.
54. Shi Y.Y., He L. SHEsis a powerful software platform for analyses of linkage disequilibrium haplotype construction and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
55. Sorrientoa D., Ciccarellia M., Santullia G., Campanilea A., Giuseppina G.A., Ciminib V., Galassoa G., Astonec D., Piscionea F., Pastorec L., Trimarcoa B., Iaccarinoa G. The G-protein-coupled receptor kinase 5 inhibits NFkB transcriptional activity by inducing nuclear accumulation of IkBα. Proc. Natl. Acad. Sci. 2008, 105:17818-17823.
56. Thomsen R., Christensen M.H. MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem. 2006, 49:3315-3321.
57. van Calker D., Muller M., Hamprecht B. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 1979, 33:999-1005.
58. Wang D., Sadée W. Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J. 2006, 8:E515-20.
59. Wang W.C., Mihlbachler K.A., Bleecker E.R., Weiss S.T., Liggett S.B. A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors. Pharmacogenet. Genomics 2008, 18:729-732.
60. WHO malaria factsheet, 2013.. http://www.who.int/mediacentre/factsheets/fs094/en/index.html.
61. Wright K., Tajouri L., Lea R.A., Ovcaric M., Heux S., Morin F., Bey W., Headrick J.P., Griffiths L.R. The role of adenosine-related genes variants in susceptibility to essential hypertension. J. Hypertens. 2004, 22:1519-1522.
62. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M. Involvement of interleukin-8 vascular endothelial growth factor and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 1997, 17:4015-4023.